Cogent Biosciences Stock Soars: A Year of Gains and a $4.5M Sell
Cogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
New costs require quick yet thoughtful budget tweaks. This section highlights practical adjustments to preserve balance and grow savings.
27,302 articlesCogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
Boot Barn stands at a crossroads in 2026. This guide breaks down the growth drivers, potential risks, and practical i...
After a dramatic fall, Canopy Growth has staged a cautious comeback. This article breaks down whether canopy growth s...
Investors are flocking to space names as Rocket Lab reports a record quarter and solid Q2 guidance. Here’s what this ...
Investors looking at cannabis real estate need to understand how Innovative Industrial Properties reports earnings. T...
Uncover what historically cheap ultra-high-yield dividend opportunities look like, why prices swing, and how to build...
As Nvidia prepares to report and guide on May 20, investors weigh the odds of a big move. This article breaks down th...
Thursday brought a notable move for AMD as shares jumped on favorable analyst commentary and a rising server CPU TAM ...
When a CEO puts real money behind his own company’s stock, investors sit up and take notice. This article breaks down...
Eli Lilly's ascent to the top of the drug charts centers on a single family of medicines. This article breaks down wh...
Lockup terms can shape the first days of a stock's life after an IPO. This guide explains standard practices, what an...
Intuitive Machines faced a notable stock slide this week as broader space-sector volatility and milestone timing conc...